Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
Stanford University
University of Chicago
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
St. Petersburg State Pavlov Medical University
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai